Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tert-butyl 4-[[1-[(4-chlorophenyl)methyl]-3-hydroxy-2-oxopyridin-4-yl]methyl]piperazine-1-carboxylate inhibit of human recombinant EGLN-1 as substrate after 20 mins by mass spectrophotometric analysis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 39.00 | |
5 mg | In stock | $ 64.00 | |
10 mg | In stock | $ 97.00 | |
25 mg | In stock | $ 185.00 | |
50 mg | In stock | $ 297.00 | |
100 mg | In stock | $ 478.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 70.00 |
Description | Tert-butyl 4-[[1-[(4-chlorophenyl)methyl]-3-hydroxy-2-oxopyridin-4-yl]methyl]piperazine-1-carboxylate inhibit of human recombinant EGLN-1 as substrate after 20 mins by mass spectrophotometric analysis. |
Molecular Weight | 433.93 |
Formula | C22H28ClN3O4 |
CAS No. | 1303512-02-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.95 mg/mL (11.41 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Izilendustat 1303512-02-8 Chromatin/Epigenetic Metabolism HIF/HIF Prolyl-Hydroxylase inmmune response HIF-PH colitis prolyl hydroxylase Inhibitor HIF-2 HIFs Hypoxia-inducible factors inflammatory bowel diseases inhibit HIF- lα inhibitor